These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

879 related articles for article (PubMed ID: 9218010)

  • 1. Hyperthermia potentiates antitumor effect of thermosensitive-liposome-encapsulated melphalan and radiation in murine melanoma.
    Chelvi TP; Ralhan R
    Tumour Biol; 1997; 18(4):250-60. PubMed ID: 9218010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated melphalan in murine tumors.
    Chelvi TP; Jain SK; Ralhan R
    Oncol Res; 1995; 7(7-8):393-8. PubMed ID: 8747602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat-mediated selective delivery of liposome-associated melphalan in murine melanoma.
    Chelvi PT; Jain SK; Ralhan R
    Melanoma Res; 1995 Oct; 5(5):321-6. PubMed ID: 8541722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermosensitive liposomal taxol formulation: heat-mediated targeted drug delivery in murine melanoma.
    Sharma D; Chelvi TP; Kaur J; Ralhan R
    Melanoma Res; 1998 Jun; 8(3):240-4. PubMed ID: 9664145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
    Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
    J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
    Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
    J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the response of B16F1 melanoma to fractionated radiotherapy and prolongation of survival by withaferin A and/or hyperthermia.
    Kalthur G; Pathirissery UD
    Integr Cancer Ther; 2010 Dec; 9(4):370-7. PubMed ID: 20713375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing of thermosensitive liposomes from natural lipids for multimodality cancer therapy.
    Chelvi TP; Ralhan R
    Int J Hyperthermia; 1995; 11(5):685-95. PubMed ID: 7594819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy.
    Ning S; Macleod K; Abra RM; Huang AH; Hahn GM
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):827-34. PubMed ID: 8040030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting chemotherapy for malignant brain tumor using thermosensitive liposome and localized hyperthermia.
    Kakinuma K; Tanaka R; Takahashi H; Watanabe M; Nakagawa T; Kuroki M
    J Neurosurg; 1996 Feb; 84(2):180-4. PubMed ID: 8592219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia.
    Lokerse WJ; Bolkestein M; Ten Hagen TL; de Jong M; Eggermont AM; Grüll H; Koning GA
    Theranostics; 2016; 6(10):1717-31. PubMed ID: 27446503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melphalan uptake, hyperthermic synergism and drug resistance in a human cell culture model for the isolated limb perfusion of melanoma.
    Clark J; Grabs AJ; Parsons PG; Smithers BM; Addison RS; Roberts MS
    Melanoma Res; 1994 Dec; 4(6):365-70. PubMed ID: 7703715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hyperthermia and irradiation on the growth of mouse melanoma tumors following immunotherapy.
    Green DM; Samulski TV; Vervaert C; Halperin EC; Oleson JR; Seigler H
    J Surg Oncol; 1990 Aug; 44(4):256-9. PubMed ID: 2385103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermochemotherapy for B16 melanoma: combination therapy of hyperthermia, melphalan, and CCNU in mice.
    Vicente V; Gomez M; Ochotorena MM; Cremades A; Canteras M
    Pigment Cell Res; 1990; 3(1):1-7. PubMed ID: 2377576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of doxorubicin thermosensitive liposomes (40 degrees C) and local hyperthermia on rat rhabdomyosarcoma.
    Morita K; Zywietz F; Kakinuma K; Tanaka R; Katoh M
    Oncol Rep; 2008 Aug; 20(2):365-72. PubMed ID: 18636199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice.
    Dou YN; Zheng J; Foltz WD; Weersink R; Chaudary N; Jaffray DA; Allen C
    J Control Release; 2014 Mar; 178():69-78. PubMed ID: 24440663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin.
    Nishimura Y; Ono K; Hiraoka M; Masunaga S; Jo S; Shibamoto Y; Sasai K; Abe M; Iga K; Ogawa Y
    Radiat Res; 1990 May; 122(2):161-7. PubMed ID: 2336462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
    Lienard D; Ewalenko P; Delmotte JJ; Renard N; Lejeune FJ
    J Clin Oncol; 1992 Jan; 10(1):52-60. PubMed ID: 1727926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.